238 related articles for article (PubMed ID: 34835053)
1. In Vivo Modelling of Hepatitis B Virus Subgenotype A1 Replication Using Adeno-Associated Viral Vectors.
Limani SW; Mnyandu N; Ely A; Wadee R; Kramvis A; Arbuthnot P; Maepa MB
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835053
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules.
Dion S; Bourgine M; Godon O; Levillayer F; Michel ML
J Virol; 2013 May; 87(10):5554-63. PubMed ID: 23468504
[TBL] [Abstract][Full Text] [Related]
3. Construction of replication competent plasmids of hepatitis B virus subgenotypes A1, A2 and D3 with authentic endogenous promoters.
Bhoola NH; Reumann K; Kew MC; Will H; Kramvis A
J Virol Methods; 2014 Jul; 203():54-64. PubMed ID: 24681050
[TBL] [Abstract][Full Text] [Related]
4. Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in Mice.
Ye L; Yu H; Li C; Hirsch ML; Zhang L; Samulski RJ; Li W; Liu Z
PLoS One; 2015; 10(6):e0130052. PubMed ID: 26075890
[TBL] [Abstract][Full Text] [Related]
5. A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNA.
Xu Z; Zhao L; Zhong Y; Zhu C; Zhao K; Teng Y; Cheng X; Chen Q; Xia Y
Cell Mol Gastroenterol Hepatol; 2022; 13(4):1001-1017. PubMed ID: 34896285
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the in vitro replication phenotype of African hepatitis B virus (HBV) genotypes and subgenotypes present in Australia identifies marked differences in DNA and protein expression.
Bannister E; Sozzi V; Mason H; Locarnini S; Hardikar W; Revill PA
Virology; 2020 Jan; 540():97-103. PubMed ID: 31765921
[TBL] [Abstract][Full Text] [Related]
7. Variability of the preC/C region of hepatitis B virus genotype A from a South African cohort predominantly infected with HIV.
Mayaphi SH; Martin DJ; Mphahlele MJ; Blackard JT; Bowyer SM
J Med Virol; 2013 Nov; 85(11):1883-92. PubMed ID: 23925707
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of HBV persistent infection mice models by different serotypes of AAVs carrying HBV genomes].
Zhu X; Zhou Q; Tian W; Liu C; Dong X; Wu X; Yu C
Sheng Wu Gong Cheng Xue Bao; 2015 Dec; 31(12):1764-72. PubMed ID: 27093839
[TBL] [Abstract][Full Text] [Related]
9. Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya.
Ochwoto M; Chauhan R; Gopalakrishnan D; Chen CY; Ng'ang'a Z; Okoth F; Kioko H; Kimotho J; Kaiguri P; Kramvis A
Infect Genet Evol; 2013 Dec; 20():103-10. PubMed ID: 23978387
[TBL] [Abstract][Full Text] [Related]
10. Long-term and efficient inhibition of hepatitis B virus replication by AAV8-delivered artificial microRNAs.
Mao Y; Wang X; Hu W; Li A; Li Y; Huang H; Yan R; Zhang Y; Li J; Li H; Wang S
Antiviral Res; 2022 Aug; 204():105366. PubMed ID: 35732226
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India.
Gopalakrishnan D; Keyter M; Shenoy KT; Leena KB; Thayumanavan L; Thomas V; Vinayakumar K; Panackel C; Korah AT; Nair R; Kramvis A
World J Gastroenterol; 2013 Dec; 19(48):9294-306. PubMed ID: 24409056
[TBL] [Abstract][Full Text] [Related]
12. [Establishment of hepatitis B virus (HBV) chronic infection mouse model by in vivo transduction with a recombinant adeno-associated virus 8 carrying 1. 3 copies of HBV genome (rAAN8-1. 3HBV)].
Dong XY; Yu CJ; Wang G; Tian WH; Lu Y; Zhang FW; Wang W; Wang Y; Tan WJ; Wu XB
Bing Du Xue Bao; 2010 Nov; 26(6):425-31. PubMed ID: 21344744
[TBL] [Abstract][Full Text] [Related]
13. Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors.
Ko C; Su J; Festag J; Bester R; Kosinska AD; Protzer U
Antiviral Res; 2021 Oct; 194():105140. PubMed ID: 34284057
[TBL] [Abstract][Full Text] [Related]
14. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HBV replication and gene expression in vitro and in vivo with a single AAV vector delivering two shRNA molecules.
Li Z; He ML; Yao H; Dong QM; Chen YC; Chan CY; Zheng BJ; Yuen KY; Peng Y; Sun Q; Yang X; Lin MC; Sung JJ; Kung HF
BMB Rep; 2009 Jan; 42(1):59-64. PubMed ID: 19192395
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of hepatitis B virus subgenotypes A1 and D4 in Maranhão state, Northeast Brazil.
Barros LM; Gomes-Gouvêa MS; Kramvis A; Mendes-Corrêa MC; dos Santos A; Souza LA; Santos MD; Carrilho FJ; de Jesus Domicini A; Pinho JR; de Souza Paiva Ferreira A
Infect Genet Evol; 2014 Jun; 24():68-75. PubMed ID: 24642137
[TBL] [Abstract][Full Text] [Related]
17. Higher detection rates of amino acid substitutions in HBV reverse transcriptase/surface protein overlapping sequence is correlated with lower serum HBV DNA and HBsAg levels in HBeAg-positive chronic hepatitis B patients with subgenotype B2.
Su M; Xiang K; Li Y; Li Y; Deng J; Xu X; Yan L; Zhuang H; Li T
Infect Genet Evol; 2016 Jun; 40():275-281. PubMed ID: 27006281
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Delivery of Cassettes Encoding Anti-HBV Primary MicroRNAs Using an Ancestral Adeno-Associated Viral Vector.
Mnyandu N; Arbuthnot P; Maepa MB
Methods Mol Biol; 2020; 2115():171-183. PubMed ID: 32006401
[TBL] [Abstract][Full Text] [Related]
19. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus.
Chen CC; Chang CM; Sun CP; Yu CP; Wu PY; Jeng KS; Hu CP; Chen PJ; Wu JC; Shih CH; Gershwin ME; Tao MH
Gene Ther; 2012 Jan; 19(1):25-33. PubMed ID: 21562593
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.
Wang Z; Zhu K; Bai W; Jia B; Hu H; Zhou D; Zhang X; Zhang X; Xie Y; Bourgine MM; Michel ML; Lan K; Deng Q
J Virol; 2014 Mar; 88(5):3004-15. PubMed ID: 24371056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
